Patents by Inventor Andhe V. N. Reddy

Andhe V. N. Reddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cephem compounds, their production and use
    Patent number: 9751894
    Abstract: Cephem compounds, pharmaceutically acceptable salts thereof, and methods of using same, wherein the compound has a bicyclic nitrogen-containing aromatic heterocyclic ring as the quaternary ammoniomethyl group at the 3-position and one or both of a terminal amidine residue (substituted or unsubstituted) attached to an aryl or a 5- or 6-membered heteroaryl group (substituted or unsubstituted) which is further attached through a spacer to the free N-atom of the quaternary nitrogen-containing bicyclic ring at the 3-side chain, or a terminal guanidine residue attached to an aryl or a 5- or 6-membered heteroaryl group (substituted or unsubstituted) which is further attached through a spacer to the free N-atom of the quaternary nitrogen-containing bicyclic ring at the 3-side chain.
    Type: Grant
    Filed: December 5, 2016
    Date of Patent: September 5, 2017
    Assignee: NAEJA-RGM PHARMACEUTICALS INC.
    Inventors: Samarendra Nath Maiti, Dai Quoc Nguyen, Andhe V. N. Reddy, Judy Yip, Chan Minh Ha, Rong Ling, Rudong Shan, Madhava Reddy Madala
  • CEPHEM COMPOUNDS, THEIR PRODUCTION AND USE
    Publication number: 20170166587
    Abstract: Cephem compounds, pharmaceutically acceptable salts thereof, and methods of using same, wherein the compound has a bicyclic nitrogen-containing aromatic heterocyclic ring as the quaternary ammoniomethyl group at the 3-position and one or both of a terminal amidine residue (substituted or unsubstituted) attached to an aryl or a 5- or 6-membered heteroaryl group (substituted or unsubstituted) which is further attached through a spacer to the free N-atom of the quaternary nitrogen-containing bicyclic ring at the 3-side chain, or a terminal guanidine residue attached to an aryl or a 5- or 6-membered heteroaryl group (substituted or unsubstituted) which is further attached through a spacer to the free N-atom of the quaternary nitrogen-containing bicyclic ring at the 3-side chain.
    Type: Application
    Filed: December 5, 2016
    Publication date: June 15, 2017
    Inventors: Samarendra Nath MAITI, Dai Quoc NGUYEN, Andhe V.N. REDDY, Judy YIP, Chan Minh HA, Rong LING, Rudong SHAN, Madhava Reddy MADALA
  • Dihydropyrimidine derivatives as cysteine protease inhibitors
    Publication number: 20040024000
    Abstract: Ditiydropyrimidine derivatives are disclosed, which can be used to inhibit cysteine protease activity.
    Type: Application
    Filed: April 11, 2003
    Publication date: February 5, 2004
    Inventors: Rajeshwar Singh, Andhe V.N. Reddy, Nian E. Zhou, Qizhu Ding, George Thomas, Jadwiga Kaleta, Ronald G. Micetich
  • Cysteine protease inhibitors
    Patent number: 6635621
    Abstract: This invention relates to derivatives of alpha-amino acid amides, to pharmaceutical compositions containing such compounds, and to their use in medicine as inhibitors of cysteine proteases, particularly the cathepsins. A compound of formula (I) is described or a pharmaceutically acceptable salt, hydrate or solvate thereof. Pharmaceutically acceptable salts of the compounds of this invention include the sodium, potassium, magnesium, calcium, hydrogen chloride, tartaric acid, succinic acid, fumaric acid and p-toluenesulfonic acid salts.
    Type: Grant
    Filed: January 30, 2002
    Date of Patent: October 21, 2003
    Assignee: Naeja Pharmaceutical Inc.
    Inventors: Rajeshwar Singh, Nian Zhou, Andhe V. N. Reddy, George Thomas, Qizhu Ding, Jadwiga Kaleta, Ronald George Micetich, Mark Whittaker
  • 2-spiro(2'-spirocycloalkyl)cyclopropyl cephalosporin sulfones as antiinflammatory and antigenerative agents
    Patent number: 5439904
    Abstract: 2-spiro (2'-spirocycloalkyl) cyclopropyl cephalosporin sulfone compounds, methods of treating patients for elastase inhibition, and processes for preparing such compounds.
    Type: Grant
    Filed: December 7, 1993
    Date of Patent: August 8, 1995
    Assignee: Synphar Laboratories, Inc.
    Inventors: Samarendra N. Maiti, Charles Y. Fiakpui, Andhe V. N. Reddy, David P. Czajkowski, Ronald G. Micetich
  • Cephem compounds, their production and use
    Patent number: RE48097
    Abstract: Cephem compounds, pharmaceutically acceptable salts thereof, and methods of using same, wherein the compound has a bicyclic nitrogen-containing aromatic heterocyclic ring as the quaternary ammoniomethyl group at the 3-position and one or both of a terminal amidine residue (substituted or unsubstituted) attached to an aryl or a 5- or 6-membered heteroaryl group (substituted or unsubstituted) which is further attached through a spacer to the free N-atom of the quaternary nitrogen-containing bicyclic ring at the 3-side chain, or a terminal guanidine residue attached to an aryl or a 5- or 6-membered heteroaryl group (substituted or unsubstituted) which is further attached through a spacer to the free N-atom of the quaternary nitrogen-containing bicyclic ring at the 3-side chain.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: July 14, 2020
    Assignee: NAEJA-RGM PHARMACEUTICALS ULC
    Inventors: Samarendra Nath Maiti, Dai Quoc Nguyen, Andhe V. N. Reddy, Judy Yip, Chan Minh Ha, Rong Ling, Rudong Shan, Madhava Reddy Madala